MindRank gets USFDA clearance of IND application for MDR-001 for treatment of Type 2 diabetes
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
Through lifestyle modifications, ADORE will assess the progress of patients based on parameters like reduction in blood sugar levels and weight, among others
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Man lost 54 Kgs in 6 months with MGB procedure
Subscribe To Our Newsletter & Stay Updated